The products are far from a proven sleep treatment.
This shift has accelerated sharply since 2023, driven by live-service models, Web3 experimentation, and growing regulatory ...
Americans love working from home. Does it love them back? A controversial new study says remote work is taking a toll on ...
Morning Overview on MSN
An experimental drug doubled one-year survival for pancreatic cancer patients
Patients with metastatic pancreatic cancer who received the experimental drug elraglusib alongside standard chemotherapy saw ...
After a four-month investigation, Nature Medicine has decided to pull a viral study that linked early-day PD-1/chemo ...
Morning Overview on MSN
Taking melatonin for over a year was tied to higher heart-failure risk in a large study
Millions of Americans who reach for melatonin each night to help them sleep now face an uncomfortable question: could the ...
A new University of Georgia network meta-analysis finds tirzepatide sitting at the top of the weight-loss heap among commonly ...
US Health and Human Services Secretary Robert F. Kennedy Jr. attacks scientific literature with censorship to push MAHA ...
Data from EULAR 2026 show that next-generation CAR T- and NK cell platforms induce powerful, drug-free clinical remissions in patients with highly refractory rheumatic diseases.
Insmed remains a Strong Buy as ARIKAYCE, TPIP Phase 3 progress and 44% YoY BRINSUPRI growth drive upside. Click here to read ...
AYO and Luminette both use light therapy, but one has stronger research behind it. Some of our team members have already tested and written about light therapy glasses separately, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results